←
Loyal324 posts
Loyal avatar

Loyal

@loyalfordogs

We’re developing the first drugs intended to help dogs live longer, healthier lives 🐕

◷ Joined October 2020▧ 123 Photos and videos
Loyal avatar
Loyal@loyalfordogs·Oct 27

1) Validate surrogate endpoints that predict long-term outcomes 2) Allow accelerated approval through a modified 505(b)(2) pathway for approved drugs with all-cause mortality benefits across multiple diseases

Loyal avatar
Loyal@loyalfordogs·Oct 27

New in GeroScience: Lessons from dog lifespan therapeutics for their human companions. Our research team proposes two strategies to help overcome the barriers to human longevity drug development, modeled on the conditional approval framework the FDA already uses in veterinary medicine and that we’re using for dog lifespan extension drugs: hubs.la/Q04Ctv520

Post attachment
Loyal avatar
Loyal@loyalfordogs·Sep 21

We're getting closer to the first longevity drugs for dogs. Hear about our latest progress from the team making it happen → hubs.la/Q04xXVds0

0:53
Loyal avatar
Loyal@loyalfordogs·Sep 16

LOY-003, our pill for large- and giant-breed dog lifespan extension, completed the efficacy section (RXE) of its conditional approval application.

Post attachment
SkeptVet avatar
⟳ Loyal retweeted
SkeptVet@SkeptVet·Sep 16

After 5 years, I am still excited to be a part of this team and this work!

When we started Loyal there was no FDA pathway for a any lifespan extension drug. Today the FDA accepted our third one! LOY-003, our daily pill for helping large dogs live longer (and healthier) lives, has earned RXE efficacy approval.

4:40
Todd Goldberg avatar
⟳ Loyal retweeted
Todd Goldberg@toddgoldberg·Sep 16

Congrats to the Loyal team! 🐶 @celinehalioua has been talking about this drug since the earliest days of Loyal. Very exciting!

When we started Loyal there was no FDA pathway for a any lifespan extension drug. Today the FDA accepted our third one! LOY-003, our daily pill for helping large dogs live longer (and healthier) lives, has earned RXE efficacy approval.

4:40
Loyal avatar
Loyal@loyalfordogs·Sep 16

We’re one step closer to the first FDA-approved longevity drugs for dogs 🐶🎉 Now, all three drugs currently in our portfolio have met the FDA’s efficacy requirements for conditional approval, a first for any pharma company.

When we started Loyal there was no FDA pathway for a any lifespan extension drug. Today the FDA accepted our third one! LOY-003, our daily pill for helping large dogs live longer (and healthier) lives, has earned RXE efficacy approval.

4:40
Loyal avatar
Loyal@loyalfordogs·Sep 15

Every dog ages differently: Which sign of aging stands out in your dog or patients?

Loyal avatar
Loyal@loyalfordogs·Sep 15

Four quick polls from the Loyal team: Are you a dog owner or veterinary professional?

Loyal avatar
Loyal@loyalfordogs·Jun 5

The A-Word: The Future of Aging premieres tonight at the 25th @Tribeca Film Festival. An independent documentary about growing old well and the founders and scientists working to add life to years. It's honest, hopeful, and our founder @celinehalioua is one of the voices in it.

Post attachment
Loyal avatar
Loyal@loyalfordogs·May 27

"If we pull this off, my team will be responsible for potentially millions of dog years that wouldn't have otherwise existed." Learn more about our journey in @BainCapVC 's latest Outlier Briefing with @kevinzhang and @celinehalioua → youtu.be/LXqF5tohXt8

This startup wants dogs to live longer. If that’s not enough to get you to watch, we’re not sure what will. But if you need more convincing, @celinehalioua built @loyalfordogs after years of doubt and is now running the first ever FDA-concurred lifespan extension clinical trial. Featuring 1,300 really good boys and girls. And yes, everyone will get a pup cup after. Full Outlier Briefing with @kevinzhang out now.

6:42